Market Need Medium-sized medical device company with a proprietary CMAPpro platform offers objective, clinically validated data on soft tissue injuries. Potential sales opportunity to hospitals, clinics, and payer organizations seeking measurable patient outcomes, improved referral efficiency, and data-driven treatment decisions.

US-Mourced Advantage Product designed, engineered and manufactured in the USA, aligning with buyers prioritizing domestic supply chains and regulatory alignment. Leverage for domestic healthcare institutions seeking trusted partners with compliant data transfer and management capabilities.

Growth Readiness Revenue range and funding indicate growth potential and ongoing investment readiness. Target mid-market health systems and regional networks that may scale CMAPpro adoption across departments to drive efficiency gains in patient visits, billing reconciliation, and outcome reporting.

Tech Enablement Existing tech stack and emphasis on automated data analysis, electronic billing, and comprehensive reporting present cross-sell or upsell opportunities to integrate with existing IT ecosystems, EMR workflows, and payer authorization processes.

Competitive Positioning Distinct focus on soft tissue pathologies and motion-captured data offers a differentiator from larger players. Engage with health systems looking for innovative, outcome-centric solutions to gain competitive advantage and favorable payer mix.